"Angitia doses first subject in Phase II trial of AGA2118 for treating osteoporosis" was originally created and published by Clinical Trials Arena, a GlobalData owned brand.

The phase 2 study included 47 patients with MCI or early AD ... Craft told attendees that longer and larger trials are ...

Viking Therapeutics has announced its oral formulation of VK2735 has scored in a Phase I trial at ObesityWeek 2024.

Anavex announced new data from their phase 2b/3 Alzheimer's trial, which was presented at the CTAD 2024 conference. Read why ...

The patient died four months after BEAM-101 infusion “due to respiratory failure that was determined by the investigator to ...

VIR's HDV and HBV treatments remain Vir's primary value drivers, with upcoming catalysts in Q4 2024 and 2025. Find out why ...

The FDA continues to approve new drugs and expand indications for others at a rapid pace. Here’s a summary of what happened ...

Medications like Ozempic and Wegovy, which are used to treat type 2 diabetes and boost weight loss, may also help reduce knee ...

The trials in phase 1, will focus on quality of services, selling and distribution, and customer centricity, sources in the ...

We will begin the MacroGenics 2024 third-quarter corporate progress and financial results conference call in just a moment.

A MAJOR trial into a potential norovirus vaccine is taking place in Weymouth. Weymouth Research Hub, based at the Linden Unit, is recruiting people to take part in a clinical trial to see if an ...

Intra-Cellular Therapies’ atypical antipsychotic medication Caplyta has been on a roll, delivering fast commercial growth and coming up triumphant in yet another late-stage trial. | Intra-Cellular ...